{"id":"W2016437276","doi":"10.1016/j.ahj.2012.06.005","title":"Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial","year":2012,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"Bayer; Servier; Eisai; Daiichi-Sankyo; Regado Biosciences; Medicines Company; Boehringer Ingelheim; Schering-Plough; Medtronic; Johnson and Johnson; Meso Scale Diagnostics; Sanofi; Novartis; Merck; GlaxoSmithKline; Otsuka America; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Roche; Astellas Pharma US; Pfizer; Abbott Laboratories; Portola Pharmaceuticals","keywords":"Ticagrelor; Medicine; Clopidogrel; Platelet inhibition; Internal medicine; Cardiology; Clinical trial; Acute coronary syndrome; Platelet; Platelet aggregation inhibitor; Aspirin; Intensive care medicine; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002762661,0.0009005947,0.001715533,0.0002909301,0.0004705146,0.001733152,0.0007827809,0.00155244,0.002220418],"category_scores_gemma":[0.004397857,0.0004475353,0.002225933,0.0006854191,0.0006362894,0.001183589,0.0007964172,0.002659073,0.0002638952],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004203397,"about_ca_system_score_gemma":0.0007420923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001472497,"about_ca_topic_score_gemma":0.002718749,"domain_scores_codex":[0.9988194,0.0006362043,0.00009972896,0.000154908,0.0001544525,0.0001352463],"domain_scores_gemma":[0.9971621,0.001201277,0.0007397311,0.0002161007,0.00008036281,0.0006004859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6019953,0.004769924,0.3425709,0.0007467086,0.01735242,0.0003794297,0.0001568564,0.001241502,0.002370862,0.0009451806,0.002672702,0.02479809],"study_design_scores_gemma":[0.07552765,0.0272794,0.8628207,0.0001926103,0.02364674,0.0004520029,0.0003287698,0.003745892,0.000828681,0.002049179,0.002987219,0.0001410817],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922857,0.004572029,0.0001263422,0.0006497543,0.0001565097,0.00005267009,0.0006667979,0.00000972419,0.001480531],"genre_scores_gemma":[0.9950854,0.002010657,0.0001839674,0.0004804258,0.0005435059,0.00008295636,0.001161215,0.000007691927,0.0004441535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002762661,"threshold_uncertainty_score":0.01461053,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03092289676265752,"score_gpt":0.3316381269638888,"score_spread":0.3007152302012313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}